Sensex 72623.09
434.31 (-0.59%)

Nifty Pharma

 Companies
Read More Read Less

Pharmaceuticals sector is one of the key sectors where Indian companies have created a global brand for themselves besides software. Indian companies have taken advantage of the opportunities in the regulated generics market in the western countries and made deep inroads especially in providing low cost equivalents of expensive drugs.Pharma outsourcing into India and low cost Healthcare services are expected to be the key areas of growth in the near future. In addition, the inherent potential of biotechnology has also attracted many new companies and this is also a key growth area for Indian companies. NSE Indices has developed Nifty Pharma Index to capture the performance of the companies in this sector.

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen:- Q: Quality, V: Valuation,PT: Price Trend

Nifty Pharma companies as on Feb-2024 |
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks


Company Name (M.Cap)
DeciZen


CMP


Price
Change


Market
Cap (Cr)


52Week
High


52Week
Low


ROE


P/E


P/BV


EV/
EBITDA


5Y Sales
Gr.(%)


5Y Profit
Gr.(%)
More Info
1
Q V PT
898.9 0.56% 25,225 922.2
31 Jan, 24
414.5
14 Mar, 23
1.26 0.00 2.84 19.12 7.44 -31.19
2
Q V+ PT
9,171 0.45% 21,026 9,255
20 Feb, 24
5,330
03 May, 23
30.17 35.25 23.99 24.02 2.37 10.39
3
Q V PT
1,596 0.40% 72,382 1,701
08 Feb, 24
628.1
31 Mar, 23
2.93 40.41 5.22 21.11 1.04 9.19
4
Q V PT
1,543 0.31% 3,69,186 1,555
12 Feb, 24
922.5
22 May, 23
16.92 41.45 5.92 26.13 10.69 26.54
5
Q V+ PT
5,405 0.03% 64,602 5,497
19 Feb, 24
2,835
02 Mar, 23
12.32 38.52 6.07 28.70 11.39 9.10
6
Q V+ PT
29,180 -0.06% 62,042 29,628
16 Feb, 24
19,909
03 Mar, 23
31.69 54.16 18.14 37.08 10.15 20.60
7
Q V+ PT
1,448 -0.25% 1,17,197 1,484
20 Feb, 24
852.0
22 Mar, 23
11.92 31.61 4.53 17.21 8.47 14.67
8
Q V PT
893.5 -0.27% 90,683 912.9
20 Feb, 24
452.2
27 Feb, 23
10.18 30.49 4.66 17.38 7.68 -0.07
9
Q V PT
6,348 -0.44% 1,06,371 6,464
20 Feb, 24
4,298
01 Mar, 23
20.88 20.35 3.96 12.33 11.55 36.08
10
Q V PT
1,948 -0.93% 32,379 2,196
07 Feb, 24
861.5
22 May, 23
10.26 40.42 3.73 23.20 17.42 19.02
11
Q V PT
1,041 -1.11% 61,682 1,177
30 Jan, 24
443.1
14 Mar, 23
6.75 31.37 3.20 22.51 4.49 -7.93
12
Q V PT
1,219 -1.36% 31,358 1,264
08 Feb, 24
670.0
22 May, 23
8.97 56.97 4.94 27.49 12.58 17.37
13
Q V PT
1,025 -1.37% 18,612 1,108
19 Feb, 24
520.6
16 Mar, 23
15.14 14.57 3.38 10.61 4.38 0.36
14
Q V PT
457.8 -1.39% 11,252 473.8
19 Feb, 24
267.9
29 Mar, 23
19.30 24.25 3.74 14.56 19.01 31.51
15
Q V PT
395.4 -1.43% 21,621 444.5
02 Jan, 24
279.6
28 Apr, 23
21.71 115.05 5.33 28.45 24.05 38.61
16
Q V+ PT
2,260 -1.53% 38,880 2,650
09 Feb, 24
1,228
03 May, 23
26.60 73.51 24.53 40.13 2.52 11.21
17
Q V+ PT
2,601 -1.61% 89,482 2,700
07 Feb, 24
1,446
01 Mar, 23
20.23 59.89 12.51 28.74 10.09 20.94
18
Q V PT
3,648 -1.69% 98,523 4,072
04 Jan, 24
2,730
14 Mar, 23
14.15 71.24 7.56 41.49 14.82 15.00
19
Q V PT
274.0 -2.66% 33,797 307.0
06 Feb, 24
191.6
21 Mar, 23
8.63 17.64 3.11 91.25 -3.80 31.80
20
Q V PT
4,471 -2.94% 21,074 4,839
06 Feb, 24
3,407
28 Mar, 23
19.73 41.97 6.19 25.09 4.26 11.01
×
×

Today's Top Gainers

Company Name CMP Price Change(%)
898.900.56%
9,170.700.45%
1,595.500.40%
1,543.400.31%
5,404.750.03%

Today's Top Losers

Company Name CMP Price Change(%)
4,471.10-2.94%
274-2.66%
3,648.45-1.69%
2,601.40-1.61%
2,260-1.53%

News about Nifty Pharma


All Indices


Nifty Pharma Companies FAQs

Intro:

Pharmaceuticals sector is one of the key sectors where Indian companies have created a global brand for themselves besides software. Indian companies have taken advantage of the opportunities in the regulated generics market in the western countries and made deep inroads especially in providing low cost equivalents of expensive drugs. In addition, the inherent potential of biotechnology has also attracted many new companies and this is also a key growth area for Indian companies. NSE Indices has developed Nifty Pharma Index to capture the performance of the companies in this sector.

Statistics:

The Nifty Pharma has delivered a CAGR of ~10% over the last decade. Pharma outsourcing into India and low cost Healthcare services are expected to be the key areas of growth in the near future. India is the largest provider of generic drugs globally. Indian pharmaceutical sector supplies ~50% of the global demand for various vaccines, 40% of generic demand in the US and 25% of all medicines in the UK. Indian pharmaceutical sector is expected to grow to US$ 100 billion, while medical device market is expected to grow US$ 25 billion by 2025.

The Union Cabinet has given its nod for the amendment of existing Foreign Direct Investment (FDI) policy in the pharmaceutical sector in order to allow FDI up to 100 per cent under the automatic route for manufacturing of medical devices subject to certain conditions.

The drugs and pharmaceuticals sector attracted cumulative FDI inflow worth US$ 16.50 billion between April 2000 and March 2020 according to the data released by Department for Promotion of Industry and Internal Trade (DPIIT).

Pharmaceuticals export from India stood at US$ 20.70 billion in FY20. Pharmaceutical export include bulk drugs, intermediates, drug formulations, biologicals, Ayush and herbal products and surgical.

India's biotechnology industry comprising biopharmaceuticals, bio-services, bio-agriculture, bio-industry, and bioinformatics is expected grow at an average growth rate of around 30 per cent a y-o-y to reach US$ 100 billion by 2025.

India's domestic pharmaceutical market turnover reached Rs 1.4 lakh crore (US$ 20.03 billion) in 2019, up 9.8% from Rs 129,015 crore (US$ 18.12 billion) in 2018.

Medicine spending in India is projected to grow 9-12% over the next five years, leading India to become one of the top 10 countries in terms of medicine spending.

Going forward, better growth in domestic sales would also depend on the ability of companies to align their product portfolio towards chronic therapies for diseases such as cardiovascular, anti-diabetes, anti-depressants and anti-cancers, which are on the rise.

The steps taken by the government to reduce costs and bring down healthcare expenses drives the revenues of the pharma companies. Speedy introduction of generic drugs into the market has remained in focus and is expected to benefit the Indian pharmaceutical companies. In addition, the thrust on rural health programmes, lifesaving drugs and preventive vaccines also augurs well for the pharmaceutical companies. Low manufacturing cost is the key advantage of Indian players and this drives their growth and profitability.

Pharma sector includes active pharmaceutical ingredients (API) industry which is a part of chemical industry. The API which happens to be the raw material used by pharma companies is manufactured by companies with speciality in chemical segments. Hence they are crucial part of the pharma chain. The sector comprises of the multiple companies specialized in generic drugs and having low manufacturing as their key advantage. Also there are some large size companies which are specialized in over-the counter drugs/ medical accessories (like inhaler by Cipla). Some companies aim for the mass market while some aim for the niche drugs.

The large size companies such as Cipla, Lupin, Sun Pharma own notable brands, have a distribution across the country, capacity to heavily spend on R&D due to their balance sheet size. Pharma companies tend to trade at premium valuations due to their defensive nature of business. The other ancillary companies are packaging companies and other contract manufacturing companies.

1. Sun Pharma
Established in 1983 by Mr. Dilip Shanghvi, Sun Pharma (SUN) is the Indian MNC that manufactures and sells pharmaceutical formulations and APIs primarily in India and the United States. Over 72% of Sun Pharma sales are from markets outside India, primarily in the United States.
The company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology and diabetology. It also provides APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anti-cancers, steroids, peptides and controlled substances.
The 2014 acquisition of Ranbaxy made Sun the largest pharma company in India, the largest Indian pharma company in the US, and the 5th largest speciality generic company globally.

Sun Pharma Growth Parameters


2. Cipla
Founded by Khwaja Abdul Hamied in 1935, Cipla Limited is an Indian MNC, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions. Cipla is the key player in OTC medical accessories like inhaler pump.

Cipla Ltd Growth Parameters

3. Lupin
Incorporated in the year 1968 by Desh Bandhu Gupta, Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai, India. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis. Lupin's research program covers the entire pharma product chain like generic research, Advanced Drug Delivery Systems, Intellectual Property Management, Novel Drug Discovery and Development and Biotechnology Research.

Lupin Ltd Growth Parameters

There is no specific index fund or ETF that can give you an exposure to all the Pharma companies. One idea is to buy stocks in the Nifty Pharma index in proportion to their weights in the index. Another idea is to gain exposure via investing in funds like DSP Healthcare, Mirae Asset Healthcare, etc.

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Abbott India Ltd. (M) Very Good 29,180 62,042 54.16 18.14 37.08 31.69
Sanofi India Ltd. (S) Very Good 9,171 21,026 35.25 23.99 24.02 30.17
Glaxosmithkline Pharmaceuticals Ltd. (M) Very Good 2,260 38,880 73.51 24.53 40.13 26.60
Laurus Labs Ltd. (S) Very Good 395.4 21,621 115.0 5.33 28.45 21.71
Dr. Reddys Laboratories Ltd. (L) Very Good 6,348 1,06,371 20.35 3.96 12.33 20.88

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Lupin Ltd. (M) Somewhat Good 1,596 72,382 138.6
Aurobindo Pharma Ltd. (M) Very Good 1,041 61,682 126.3
Glenmark Pharmaceuticals Ltd. (S) Somewhat Good 898.9 25,225 106.8
Zydus Lifesciences Ltd. (M) Very Good 893.5 90,683 90.72
Natco Pharma Ltd. (S) Very Good 1,025 18,612 87.05
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Laurus Labs Ltd. (S) Very Good 395.4 21,621 115.0 5.33 28.45 24.05
Granules India Ltd. (S) Somewhat Good 457.8 11,252 24.25 3.74 14.56 19.01
Gland Pharma Ltd. (M) Very Good 1,948 32,379 40.42 3.73 23.20 17.42
Divis Laboratories Ltd. (L) Very Good 3,648 98,523 71.24 7.56 41.49 14.82
Ipca Laboratories Ltd. (M) Very Good 1,219 31,358 56.97 4.94 27.49 12.58

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Laurus Labs Ltd. (S) Very Good 395.4 21,621 115.0 5.33 28.45 38.61
Dr. Reddys Laboratories Ltd. (L) Very Good 6,348 1,06,371 20.35 3.96 12.33 36.08
Biocon Ltd. (M) Somewhat Good 274.0 33,797 17.64 3.11 91.25 31.80
Granules India Ltd. (S) Somewhat Good 457.8 11,252 24.25 3.74 14.56 31.51
Sun Pharmaceutical Industries Ltd. (L) Very Good 1,543 3,69,186 41.45 5.92 26.13 26.54

MoneyWorks4me can help you identify the best performing Pharma sector stocks. The decision maker allows for simple and effective analysis.

Decision Maker

Sign up now to start a successful investing journey!

When to buy Bluechip stocks for highest returns?

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.